Eunika Therapeutics Private Limited, a active private limited company, was established on 14 September 2016 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51900BR2016PTC032522. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 33 professional, Its leadership includes Mukesh Kumar Raj (Director), Rajat Dutta (Director), Anil Kumar (Director). It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H/O Shivjee Sharma, Ashok Nagar, Road No 8 Kankarbagh, Patna, Bihar, 800020.
U51900BR2016PTC032522
032522
14 September 2016
₹1.00 M
₹1.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Eunika Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Kumar Raj | Director | 14 Sep 2016 | Current |
| Rajat Dutta | Director | 14 Sep 2016 | Current |
| Anil Kumar | Director | 14 Sep 2016 | Current |
| Brij Bhushan Prasad | Director | 14 Sep 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eunika Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.69% increase. The company also saw a substantial improvement in profitability, with a 46.47% increase in profit. The company's net worth Soared by an impressive increase of 21.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Eunika Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2022 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Eunika Therapeutics has a workforce of 33 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eunika Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eunika Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eunika Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Eunika Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was documented.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100566877 was registered on 16 Apr 2022. was recorded as a recent event.
Mukesh Kumar Raj was appointed as a Director was appointed as a Director on 14 Sep 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
Rajat Dutta was appointed as a Director was appointed as a Director on 14 Sep 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
The activity Anil Kumar was appointed as a Director was appointed as a Director on 14 Sep 2016 & has been associated with this company since 9 years 3 months . was completed.
The CIN of Eunika Therapeutics Private Limited is U51900BR2016PTC032522.
Eunika Therapeutics Private Limited is headquartered at H/O Shivjee Sharma, Ashok Nagar, Road No 8 Kankarbagh, Patna, Bihar, 800020.
Eunika Therapeutics Private Limited was incorporated on 14 September 2016.
The current directors of Eunika Therapeutics Private Limited are
The primary industry of Eunika Therapeutics Private Limited is Manufacturing.
Eunika Therapeutics Private Limited is unlisted.
The authorized capital of Eunika Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Eunika Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX